Outsourcing

Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Navigating the Preclinical CRO Outsourcing Process

The need for preclinical testing expertise is growing as molecular complexity increases.

A Closer Look at Affinity Ligands

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Gaining Formulation Expertise through Partnerships

February 01, 2022

A key benefit for companies when outsourcing formulation development is the broad experience they can gain from a dedicated service provider, particularly for niche markets.

What Outsourcing Partners Wish You Knew

February 01, 2022

Industry experts share their top outsourcing tips from both the perspective of companies offering outsourcing services as well as for companies looking to outsource.

Evolving Demands of Process Development Services

February 01, 2022

Shifting demands from industry innovators is leading to an increased need for flexible and agile outsourcing partners offering broad and integrated models.

Preparing for the Future: Expanding Capacity and Facilitating Multi-modalities

February 01, 2022

CDMOs need to consistently demonstrate agility as demand increases for newly developed therapeutic modalities.

Spray Drying Finds Growing Use for ASDs

February 01, 2022

CDMOs offer expertise and capacity for spray drying.

Fostering Orphan Drugs

February 01, 2022

CDMOs offer expertise and customization options for sponsors of orphan drugs.

Pharmaceutical Technology Europe, BioPharma Outsourcing Innovation, February 2022

February 01, 2022

Pharmaceutical Technology Europe's BioPharma Outsourcing Innovation supplement examines outsourcing development services, spray draying, capacity challenges, and more.

Texcell North America Builds New Laboratory Facility

January 28, 2022

Texcell North America’s new lab facility in Frederick, Md., will expand the CRO’s capabilities in R&D cell culture, viral clearance studies, and viral safety testing.

Samsung Biologics to Acquire Full Ownership of Samsung Bioepis in $2.3 Billion Deal

January 28, 2022

Samsung Biologics has signed an agreement with Biogen to acquire Biogen’s 50% stake in Samsung Bioepis, a joint venture formed by the two companies, for up to $2.3 billion.

Air France KLM Martinair Cargo and Envirotainer Collaborate on Sustainability

January 21, 2022

Air France KLM Martinair Cargo and Envirotainer are collaborating on more sustainable air transport of pharmaceuticals